Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.

Augmented cystine-glutamate exchange by pituitary adenylate cyclase-activating polypeptide signaling via the VPAC1 receptor.
复制标题

DOI:
10.1002/syn.21772
复制
发表时间:
2014-12
期刊:
影响因子:
2.3
通讯作者:
Choi, Sujean
Choi, Sujean
中科院分区:
医学4区
文献类型:
--
作者:
Resch, Jon M.;Albano, Rebecca;Liu, Xiaoqian;Hjelmhaug, Julie;Lobner, Doug;Baker, David A.;Choi, Sujean

文献摘要

参考文献

被引文献

相似文献

In the central nervous system, cystine import in exchange for glutamate through system xc− is critical for the production of the antioxidant glutathione by astrocytes, as well as the maintenance of extracellular glutamate. Therefore, regulation of system xc− activity affects multiple aspects of cellular physiology and may contribute to disease states. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuronally-derived peptide that has already been demonstrated to modulate multiple aspects of glutamate signaling suggesting PACAP may also target activity of cystine-glutamate exchange via system xc−. In the current study, 24-hour treatment of primary cortical cultures containing neurons and glia with PACAP concentration-dependently increased system xc− function as measured by radiolabeled cystine uptake. Furthermore, the increase in cystine uptake was completely abolished by the system xc− inhibitor, (S)-4-carboxyphenylglycine (CPG), attributing increases in cystine uptake specifically to system xc− activity. Time course and quantitative PCR results indicate that PACAP signaling may increase cystine-glutamate exchange by increasing expression of xCT, the catalytic subunit of system xc−. Furthermore, the potentiation of system xc− activity by PACAP occurs via a PKA-dependent pathway that is not mediated by the PAC1R, but rather the shared vasoactive intestinal polypeptide receptor VPAC1R. Finally, assessment of neuronal, astrocytic, and microglial-enriched cultures demonstrated that only astrocyte-enriched cultures exhibit enhanced cystine uptake following both PACAP and VIP treatment. These data introduce a novel mechanism by which both PACAP and VIP regulate system xc− activity.
DOI: 10.1152/jn.2000.83.5.2835
发表时间: 2000-05-01
影响因子: 2.5
作者:
Diamond, JS;Jahr, CE
通讯作者: Jahr, CE
DOI: 10.1006/mcne.2000.0840
发表时间: 2000-05-01
影响因子: 3.5
作者:
Brown, DR
通讯作者: Brown, DR
DOI: 10.1073/pnas.96.23.13468
发表时间: 1999-11-09
影响因子: 11.1
作者:
Chen, D;Buchanan, GF;Gillette, MU
通讯作者: Gillette, MU
DOI: 10.1016/j.biopsych.2006.11.021
发表时间: 2007-09-15
影响因子: 10.6
作者:
Grant, Jon E.;Kim, Suck Won;Odlaug, Brian L.
通讯作者: Odlaug, Brian L.
DOI: 10.1111/j.1749-6632.1994.tb19825.x
发表时间: 1994-01-01
期刊: MODELS OF NEUROPEPTIDE ACTION
影响因子: --
作者:
ARIMURA, A;SOMOGYVARIVIGH, A;BRENNEMAN, DE
通讯作者: BRENNEMAN, DE